Daniel FulopMD, MSc

MD · Mount Sinai

Residency · Internal Medicine Residencyalumni

ORCID 0000-0003-1964-4861

publications

first author

median RCR

3.98

citations

Publications

2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate Fibrosis
Clinical and Molecular Hepatology0 citesPMID 41215582
2025
Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy
JNCI Cancer Spectrum3 citesPMID 39982394
2023
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
JAMA Network Openfirst authorRCR 3.9840 citesPMID 36951863
2019
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment
Science Translational Medicine
2017
Knockdown of miR-23, miR-27, and miR-24 Alters Fetal Liver Development and Blocks Fibrosis in Mice
Gene Expression

Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.